(September 09 05:09) Forbes.com
Maya Martinez-Davis is trying to change that. As President of GlaxoSmithKline (GSK) in the US, she oversees the company’s complex portfolio of therapeutics. She's also aiming to increase the number of women and minorities in senior roles in the UK and US to 30% by the end of 2025.
You can find the original article
here